Skip to main content
Top
Published in: Lung 6/2016

01-12-2016

Lung Clearance Index (LCI) in Patients with Bronchiolitis Obliterans: A Preliminary Report and Comparison to Cystic Fibrosis Patients

Authors: Michal Gur, Karin Yaacoby-Bianu, Anat Ilivitzki, Ronen Bar-Yoseph, Vered Nir, Fahed Hakim, Yazeed Toukan, Lea Bentur

Published in: Lung | Issue 6/2016

Login to get access

Abstract

Introduction

Bronchiolitis obliterans (BO) is a chronic airway disease following an insult to the lower respiratory tract. Lung clearance index (LCI) measures ventilation inhomogeneity and has been studied in cystic fibrosis (CF). We aimed to evaluate LCI in BO and to compare it to LCI in CF patients.

Methods

LCI was measured in BO patients, compared to CF patients, and correlated with spirometry and CT findings.

Results

Twenty BO patients and 26 CF patients (with similar mean age and BMI) underwent evaluation. FEV1 % and FEF25–75 % predicted were significantly lower in the BO group (60.5 ± 17.8 vs. 72.7 ± 20.7, p = 0.041, and 42.8 ± 22.8 vs. 66.4 ± 37.4, p = 0.017, respectively). In both groups, LCI was inversely correlated with FVC %, FEV1 %, and FEF25–75 % predicted. LCI  % was slightly higher (190.4 ± 63.5 vs. 164.9 ± 39.4, p = 0.1) and FRC gas % (measured by multiple breath washout) was significantly higher in the BO group (92.5 ± 35.9 vs. 71.3 ± 18, p = 0.014). The strength of statistical association between the lower FEF25–75 % values and the higher LCI values was stronger in BO patients.

Conclusions

Similar to CF, LCI may provide estimation of ventilation inhomogeneity in BO. The results indicate greater small airway involvement and air trapping in BO. Further prospective longitudinal studies evaluating the correlation of LCI measurements with multiple clinical and physiological parameters should be performed to assess the clinical benefit of LCI measurement in BO.
Literature
1.
5.
go back to reference Fuchs SI, Eder J, Ellemunter H, Gappa M (2009) Lung clearance index: normal values, repeatability, and reproducibility in healthy children and adolescents. Pediatr Pulmonol 44:1180–1185. doi:10.1002/ppul.21093 CrossRefPubMed Fuchs SI, Eder J, Ellemunter H, Gappa M (2009) Lung clearance index: normal values, repeatability, and reproducibility in healthy children and adolescents. Pediatr Pulmonol 44:1180–1185. doi:10.​1002/​ppul.​21093 CrossRefPubMed
18.
go back to reference Gustafsson PM, Källman S, Ljungberg H, Lindblad A (2003) Method for assessment of volume of trapped gas in infants during multiple-breath inert gas washout. Pediatr Pulmonol 35:42–49. doi:10.1002/ppul.10221 CrossRefPubMed Gustafsson PM, Källman S, Ljungberg H, Lindblad A (2003) Method for assessment of volume of trapped gas in infants during multiple-breath inert gas washout. Pediatr Pulmonol 35:42–49. doi:10.​1002/​ppul.​10221 CrossRefPubMed
20.
go back to reference Quanjer PH, Borsboom GJ, Brunekreef B et al (1995) Spirometric reference values for white European children and adolescents: polgar revisited. Pediatr Pulmonol 19:135–142CrossRefPubMed Quanjer PH, Borsboom GJ, Brunekreef B et al (1995) Spirometric reference values for white European children and adolescents: polgar revisited. Pediatr Pulmonol 19:135–142CrossRefPubMed
23.
go back to reference Wuensch KL (2016) Comparing correlation coefficients, Slopes, and Intercepts pp 1–4 Wuensch KL (2016) Comparing correlation coefficients, Slopes, and Intercepts pp 1–4
24.
go back to reference Shapiro AJ, Zariwala MA, Ferkol T et al (2016) Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: pCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol 51:115–132. doi:10.1002/ppul.23304 CrossRefPubMed Shapiro AJ, Zariwala MA, Ferkol T et al (2016) Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: pCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol 51:115–132. doi:10.​1002/​ppul.​23304 CrossRefPubMed
25.
go back to reference Bandeira T, Negreiro F, Ferreira R et al (2011) Clinical, radiological, and physiological differences between obliterative bronchiolitis and problematic severe asthma in adolescents and young adults: the early origins of the overlap syndrome? Pediatr Pulmonol 46:573–580. doi:10.1002/ppul.21405 CrossRefPubMed Bandeira T, Negreiro F, Ferreira R et al (2011) Clinical, radiological, and physiological differences between obliterative bronchiolitis and problematic severe asthma in adolescents and young adults: the early origins of the overlap syndrome? Pediatr Pulmonol 46:573–580. doi:10.​1002/​ppul.​21405 CrossRefPubMed
36.
go back to reference Chan PW, Muridan R, Debruyne JA (2000) Bronchiolitis obliterans in children: clinical profile and diagnosis. Respirology 5:369–375CrossRefPubMed Chan PW, Muridan R, Debruyne JA (2000) Bronchiolitis obliterans in children: clinical profile and diagnosis. Respirology 5:369–375CrossRefPubMed
Metadata
Title
Lung Clearance Index (LCI) in Patients with Bronchiolitis Obliterans: A Preliminary Report and Comparison to Cystic Fibrosis Patients
Authors
Michal Gur
Karin Yaacoby-Bianu
Anat Ilivitzki
Ronen Bar-Yoseph
Vered Nir
Fahed Hakim
Yazeed Toukan
Lea Bentur
Publication date
01-12-2016
Publisher
Springer US
Published in
Lung / Issue 6/2016
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9934-8

Other articles of this Issue 6/2016

Lung 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.